CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: December 17, 2010
Result type: Reports
Project Number: SR0222-000
Product Line: Reimbursement Review

Generic Name: Cyclosporine

Brand Name: Restasis ophthalmic emulsion

Manufacturer: Allergan Inc.

Therapeutic Area: Dry eye disease

Indications: Dry eye disease, Moderate to moderately severe

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: July 18, 2011

Recommendation Type: Do not list